老年营养风险指数 (GNRI) 和胰腺癌生存率:一项回顾性研究
Christina Grinstead1, Saunjoo L Yoon1
1Department of Biobehavioral Nursing Science, College of Nursing, University of Florida, 1225 Center Drive, P.O. Box 100187, Gainesville, FL 32610-0187, USA.
Nutrients
|February 13, 2025
概括
诊断时较低的老年营养风险指数 (GNRI) 评分和随着时间的推移降低的GNRI评分预测胰腺癌患者的生存率降低. 早期识别GNRI营养风险可以指导干预措施以改善结果.
科学领域:
- 在瘤学瘤学.
- 营养科学 营养科学
- 老年病的医生 老年病的医生
背景情况:
- 营养不良显著影响胰腺癌患者的治疗结果.
- 瘤学中的营养评估缺乏标准化.
- 老年营养风险指数 (GNRI) 为营养风险评估提供了一个实用的工具.
研究的目的:
- 分析诊断时GNRI和随时间变化的GNRI与胰腺癌患者的整体存活率之间的关联.
- 评估GNRI作为胰腺癌生存的预测工具.
主要方法:
- 对314名胰腺癌患者 (年龄≥18岁) 的回顾性研究.
- 在诊断时和≥30天后计算的GNRI.
- 使用卡普兰-梅尔曲线和考克斯比例危险模型分析的生存率.
主要成果:
- 在诊断时任何营养风险 (GNRI ≤98) 的患者的中位生存时间 (442 vs. 1105天) 显着较低.
- 随着时间的推移,GNRI的严重下降与生存时间大幅减少 (372.5天) 相比,没有变化/增加 (1791天).
- 降低的GNRI得分 (轻度和重度) 独立预测了减少的生存率,即使在控制癌症阶段后.
结论:
- 较低和下降的GNRI得分是胰腺癌生存率下降的重要预测因素.
- GNRI是一个潜在的有效和有效的工具,用于早期识别需要营养干预的高风险患者.
- 建议对更大的队列和多种变量进行进一步研究,以确认发现并探索混因素.
相关概念视频
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube through...
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube through...
Chronic Pancreatitis II: Collaborative Care
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...


